ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04144	Endocytosis	18/140	342/7206	0.000100971147946
ko04520	Adherens junction	9/140	103/7206	0.000162646713579
ko00515	Mannose type O-glycan biosynthesis	4/140	25/7206	0.00125702283062
ko04391	Hippo signaling pathway - fly	7/140	90/7206	0.00175395628987
ko04350	TGF-beta signaling pathway	7/140	103/7206	0.00377621784242
ko04012	ErbB signaling pathway	7/140	109/7206	0.00515917622086
ko05223	Non-small cell lung cancer	5/140	66/7206	0.00891488883763
ko05200	Pathways in cancer	18/140	492/7206	0.00966839846007
ko00564	Glycerophospholipid metabolism	6/140	99/7206	0.0123589871969
ko00310	Lysine degradation	5/140	73/7206	0.0134569656099
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/140	26/7206	0.013457883446
ko04140	Autophagy - animal	8/140	164/7206	0.0143115581407
ko01521	EGFR tyrosine kinase inhibitor resistance	6/140	106/7206	0.0168636773628
ko04080	Neuroactive ligand-receptor interaction	2/140	423/7206	0.0171974558178
ko05214	Glioma	5/140	79/7206	0.0184205515086
ko05215	Prostate cancer	6/140	111/7206	0.020702495019
ko05206	MicroRNAs in cancer	8/140	177/7206	0.0216653055532
ko04392	Hippo signaling pathway -multiple species	3/140	31/7206	0.02168899207
ko05218	Melanoma	5/140	85/7206	0.024464522584
ko05220	Chronic myeloid leukemia	5/140	85/7206	0.024464522584
ko04390	Hippo signaling pathway	8/140	188/7206	0.0297138370431
ko04066	HIF-1 signaling pathway	6/140	123/7206	0.0322357335185
ko05211	Renal cell carcinoma	5/140	96/7206	0.0385733829312
ko04068	FoxO signaling pathway	7/140	167/7206	0.0436745764232
ko04530	Tight junction	9/140	228/7206	0.0437380780971